In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...

Enhanced Cognitive Performance: Vyvamind is designed to serve as a potent neurostimulant, utilizing a precise blend of ...

There are several online platforms with medical professionals who are qualified to diagnose you with ADHD. After being ...

Introduction Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent neurodevelopmental disorders and is a persistent pattern of inattention and ...

Knight Therapeutics Inc. ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PMtm, an extended-release formulation of ...

Some might roll their eyes about yet another trending health label attached to a condition that is slippery to define. Yet ...

ADHD or Attention Deficit Hyperactivity Disorder is a growing issue for many families and wider communities around Ireland.

A New Zealand addiction specialist says the disorder should not be downplayed, but we run the risk of pathologising normal ...

However, caffeine shouldn't be considered a treatment for ADHD and it should be used with care. Too much can cause unwanted ...

Telehealth companies will be able to continue prescribing controlled substances to patients without an office visit until at ...

About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...

A mood altering prescription is not a bad thing. In fact, we should thank God that we live in 2024 when so many psychotropic ...